European Penny Stocks To Watch In August 2026

European markets have shown resilience with the STOXX Europe 600 Index rising by 1.70% recently, supported by a firmer risk appetite and robust earnings despite ongoing geopolitical uncertainties. Investing in penny stocks, a term that may seem outdated yet remains relevant, offers unique growth opportunities often found in smaller or newer companies. When these stocks are underpinned by strong financial health and solid fundamentals, they can present attractive prospects for investors looking to capitalize on hidden gems within the market.

Let's review some notable picks from our screened stocks.

Freelance.com (ENXTPA:ALFRE)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Freelance.com SA facilitates intermediation between companies and intellectual service providers across several countries including France, Germany, and the UK, with a market cap of €145.76 million.

Operations: The company generates its revenue of €1.05 billion from business services.

Market Cap: €145.76M

Freelance.com SA, with a market cap of €145.76 million and revenue of €1.05 billion, presents a mixed picture for investors interested in penny stocks. The company's Return on Equity is low at 12.6%, but its interest payments are well covered by EBIT at 4.9 times coverage, and it has reduced its debt to equity ratio from 78.6% to 61.2% over five years, demonstrating improved financial stability. Although earnings grew by 29.7% last year—surpassing the industry average—the forecast predicts a decline of about 20% annually over the next three years, signaling potential challenges ahead despite stable weekly volatility and satisfactory net debt levels.

• Jump into the full analysis health report here for a deeper understanding of Freelance.com.
• Review our growth performance report to gain insights into Freelance.com's future.

BIOTON (WSE:BIO)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: BIOTON S.A. is a biotechnology company that develops, manufactures, markets, and sells pharmaceutical ingredients and medicinal products in Poland and internationally, with a market cap of PLN334.87 million.

Operations: The company's revenue primarily comes from its BIOLEK segment, which generated PLN25.83 million.

Market Cap: PLN334.87M

BIOTON S.A., with a market cap of PLN334.87 million, offers a complex profile for penny stock investors. Despite reporting a net loss of PLN5.15 million in Q1 2026, it has achieved profitability over the past year, although earnings growth remains challenging to compare historically due to its recent transition from losses. The company's financial health is bolstered by satisfactory debt levels and adequate short-term asset coverage for both short and long-term liabilities. However, its Return on Equity is low at 0.7%, and interest payments are not well covered by EBIT, indicating areas that require attention despite stable weekly volatility and high-quality earnings.

• Click here to discover the nuances of BIOTON with our detailed analytical financial health report.
• Explore historical data to track BIOTON's performance over time in our past results report.

q.beyond (XTRA:QBY0)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: q.beyond AG operates in the cloud, applications, artificial intelligence (AI), and security sectors both in Germany and internationally, with a market cap of €88.20 million.

Operations: The company has not reported any specific revenue segments.

Market Cap: €88.2M

q.beyond AG, with a market cap of €88.20 million, presents a mixed picture for penny stock investors. The company operates debt-free and has not diluted shareholders recently, which can be appealing in terms of financial stability. However, recent earnings reports show declining sales and increasing net losses compared to the previous year, indicating profitability challenges despite becoming profitable over the past five years. The launch of their “AI Act as a Service” could drive future growth by addressing regulatory needs in AI deployment across sectors. Analysts expect significant price appreciation potential despite current low Return on Equity levels.

• Get an in-depth perspective on q.beyond's performance by reading our balance sheet health report here.
• Examine q.beyond's earnings growth report to understand how analysts expect it to perform.

Summing It All Up

• Click this link to deep-dive into the 305 companies within our European Penny Stocks screener.
• Searching for a Fresh Perspective? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com